Status:
RECRUITING
Deuterium Metabolic Imaging in People with Multiple Sclerosis
Lead Sponsor:
University of Aarhus
Conditions:
Multiple Sclerosis (MS) - Relapsing-remitting
Eligibility:
All Genders
18-60 years
Brief Summary
The goal of this case-control study is to investigate glucose brain metabolism in people with multiple sclerosis and age- and sex-matched healthy controls. The main questions it aims to answer are: *...
Eligibility Criteria
Inclusion
- Aged 18-60 years.
- Definite Relapsing remitting multiple sclerosis diagnosis according to the most recent diagnostic criteria
Exclusion
- Contraindications for MRI:
- Pacemaker, neurostimulator or cholera implant. Metal foreign bodies such as fragments and irremovable piercings. Unsafe medical implants (safety of heart valves, hips and the like must be confirmed).
- Claustrophobia. Largest circumference including arms \> 160 cm
- Pregnancy
- Competing neurological, psychiatric, or systemic diseases including diabetes (except prior TIA, unspecific brain MRI findings, hypertension, atherosclerosis and hyperlipidemia/cholesterolemia which are allowed).
- Participating in other clinical trials with investigational medical products or drugs.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06611280
Start Date
October 1 2024
End Date
May 1 2026
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University
Aarhus C, Denmark, 8000